Protecting your intellectual property
Discovery Partnerships with Academia (DPAc) collaborations are shared commitments that lead to a shared reward and investment. At all times, we aim to make you aware of the implications toward your intellectual property.
We want this to be a true collaboration, sharing ideas together, publishing on a mutually agreed schedule and sharing in financial rewards if a medicine is commercialized.
Before you submit:
- Ensure your initial application does not contain confidential information that may be patentable, and that GSK can use the application for informational purposes as per the Terms and Agreement.
- Consult with your technical transfer office (TTO) and all other necessary groups to ensure that you have your institution’s permission for us to start a review.
TTO correspondence and information.
A critical component for DPAc collaborations is the review of intellectual property rights of universities, investigators and GSK.
When an application is submitted, an institution’s TTO staff member must sign-off and waive any claims of confidentiality. It is also necessary to receive the endorsement of all appropriate persons/groups/departments at your institution, complying with the institution’s interests, internal policies, procedures and regulations.
In the absence of a TTO, the researcher submitting the proposal must acknowledge in writing the non-confidential nature of the initial application.